Tranexamic Acid for Hemostasis in the Surgical Treatment of Metastatic Tumors of the Spine
Authors:
- Drew A. BednarDBDrew A. Bednar
- Vasiliki A. BednarVBVasiliki A. Bednar
- Ali ChaudharyACAli Chaudhary
- Forough FarroukhyarFFForough Farroukhyar
- 1 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 31 (8) , 954-957
Abstract
This is a retrospective study of sequential cohorts. To assess the efficacy of tranexamic acid in decreasing operative blood loss and the need for intraoperative transfusion in metastatic spine surgery. Significant published data have established the efficacy of antifibrinolytic drugs in limiting surgical bleeding during heart surgery and total joint replacement. One study in scoliosis suggested benefit in spine surgery as well. During a 6-month trial period, 14 patients with spine cancer undergoing palliative intralesional tumor excision and concomitant instrumentation to stabilize the spine in the hands of a single surgeon were administered tranexamic acid intraoperatively in the attempt to minimize operative blood loss. They were then compared to the immediately preceding 14 patients. Estimated operative blood loss was 1385 mL in the study group treated with tranexamic acid and 1815 mL in controls not receiving the drug, and was not found to be significantly decreased in this study. Control of operative bleeding in metastatic spine surgery can be problematical. Optimum protocol might include routine preoperative angiographic tumor embolization to decrease lesion vascularity in all cases, but angiography is not without risk. Noninvasive prophylaxis of tumor bleeding would have obvious desirable advantages but was, unfortunately, not achieved in this study.Keywords
This publication has 20 references indexed in Scilit:
- Bone bleeding during total hip arthroplasty after administration of tranexamic acidThe Journal of Arthroplasty, 2004
- Tranexamic acid reduces blood loss after cementless total hip arthroplasty?prospective randomized study in 40 casesInternational Orthopaedics, 2004
- Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacementCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2004
- The use of tranexamic acid to reduce blood loss during total knee arthroplastyThe Knee, 2003
- Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysisAnaesthesia and Intensive Care, 2003
- Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplastyA prospective randomized double-blind study in 40 patientsActa Orthopaedica, 2003
- Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled studyActa Anaesthesiologica Scandinavica, 2002
- Tranexamic Acid Reduces Blood Loss in Total Hip Replacement SurgeryAnesthesia & Analgesia, 2000
- Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplastyBritish Journal of Anaesthesia, 1999
- Tranexamic AcidDrugs, 1999